ChromaDex signs distribution agreement for its patented pterostilbene
date:Jul 21, 2012
the company is looking forward to the national expansion of pTeroPure and its adoption in several consumer products.
With our recently announced pTeroPure clinical safety results and the forthcoming human efficacy data, Glanbia should be well positioned to bring our exciting novel patented and proven ingredient to the food beverage, dietary supplement, and animal health markets, Jaksch added.
ChromaDex provides proprietary, science-based solutions and ingredients to the dietary supplement, foo
2/3 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/04 09:07